- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: A multi center clinical trial
Total 495024 results
-
Ferring PharmaceuticalsNot yet recruiting
-
Eli Lilly and CompanyNot yet recruitingOverweight and ObesityUnited States, Canada, Australia, Germany, Mexico, Argentina, Brazil, Hungary, Austria, India, Poland, Slovakia, Spain, Netherlands, Turkey, Czechia, United Kingdom, Denmark, Puerto Rico, France, Israel
-
JHSPH Center for Clinical TrialsNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingChronic Obstructive Pulmonary Disease (COPD)United States
-
Eli Lilly and CompanyRegeneron PharmaceuticalsNot yet recruitingObesityUnited States, Mexico
-
Eli Lilly and CompanyCipla Ltd.RecruitingDiabetes Mellitus, Type 2India
-
Sanofi Pasteur, a Sanofi CompanyRecruitingInfluenza ImmunizationUnited States, Puerto Rico
-
Eli Lilly and CompanyNot yet recruitingType 2 Diabetes MellitusUnited States
-
Eli Lilly and CompanyNot yet recruitingDiabetes Type 2United States, India, Mexico, Puerto Rico
-
Active Genomes Expressed Diagnostics, CorpWalter Reed National Military Medical Center; Arizona Clinical TrialsNot yet recruitingHealthy | NAFLD | NASH With FibrosisUnited States
-
Novo Nordisk A/SRecruitingDiabetes, Type 2United States, India, Spain, Poland, South Africa, Bulgaria, Germany, Japan, Puerto Rico
-
Eli Lilly and CompanyNot yet recruitingPerennial Allergic Rhinitis (PAR)United States
-
Acumen PharmaceuticalsRecruitingAlzheimer DiseaseUnited States, France, Italy, Germany, Spain, Canada, Poland, United Kingdom
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Serbia, Italy, Poland, China, Hungary, Saudi Arabia
-
Novo Nordisk A/SRecruitingType 2 DiabetesUnited States, Japan, Serbia, South Africa, China, Slovakia
-
ViiV HealthcareGlaxoSmithKlineNot yet recruiting
-
Eli Lilly and CompanyRecruiting
-
Eli Lilly and CompanyNot yet recruitingAlzheimer DiseaseUnited States, United Kingdom, Japan
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Argentina, United Kingdom, Puerto Rico
-
Eli Lilly and CompanyRecruitingElevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)Taiwan, United States, Spain, Argentina, China, Italy, Australia, France, Canada, Japan, Belgium, Denmark, Germany, Hungary, Israel, Austria, Korea, Republic of, Brazil, Mexico, Netherlands, Romania, United Kingdom, Greece, Czechia, India, Slovak... and more
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
Materia Medica HoldingRecruitingCystitis Chronic | Cystitis Bacterial | Recurrence of Chronic Bacterial CystitisRussian Federation
-
Eli Lilly and CompanyNot yet recruitingAtopic DermatitisChina, Korea, Republic of
-
Materia Medica HoldingRecruitingPneumonia | Community-acquired PneumoniaRussian Federation
-
Eli Lilly and CompanyRecruitingDiabetes Mellitus, Type 2United States, Canada, Mexico, Argentina, Puerto Rico
-
Sun Yat-sen UniversityRecruitingRecurrent or Metastatic Nasopharyngeal CarcinomaChina
-
M.D. Anderson Cancer CenterRecruitingIntra-abdominal CancerUnited States
-
Eli Lilly and CompanyRecruitingObesity | Overweight and ObesityUnited States
-
Regeneron PharmaceuticalsRecruitingB-Cell Non-Hodgkin Lymphoma (B-NHL)Taiwan, Spain, Korea, Republic of, Thailand, Italy, Malaysia, Turkey, Australia
-
Eli Lilly and CompanyRecruitingMultiple SclerosisUnited States, Poland, Germany, Italy, France, Israel, Latvia, Lithuania, Slovakia, United Kingdom
-
Novo Nordisk A/SRecruitingHeart Failure | Systemic InflammationUnited States, Greece, France, Australia, Czechia, Spain, India, Canada, Turkey, Portugal, Malaysia, Poland, United Kingdom, Germany, Bulgaria, Argentina
-
Eli Lilly and CompanyRecruitingType 2 DiabetesUnited States, Taiwan, China, Mexico, Germany, Poland
-
PfizerRecruitingPneumococcal DiseaseUnited States
-
BioNTech SEPfizerRecruiting
-
Eli Lilly and CompanyRecruitingPlaque PsoriasisUnited States
-
GlaxoSmithKlineMedicines for Malaria VentureRecruitingMalaria, FalciparumUnited Kingdom
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingPembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin LymphomaClassic Hodgkin LymphomaUnited States
-
Apellis Pharmaceuticals, Inc.Recruiting
-
Mineralys Therapeutics Inc.RecruitingHypertensionUnited States, Italy, Germany, Australia, Canada, United Kingdom, Puerto Rico, Bulgaria, Spain
-
Biomea Fusion Inc.RecruitingType 1 Diabetes MellitusUnited States, Canada
-
Eli Lilly and CompanyRecruiting
-
Mitsubishi Tanabe Pharma America Inc.RecruitingErythropoietic Protoporphyria (EPP) | X-Linked Protoporphyria (XLP)United States, Spain, France, Japan, United Kingdom, Italy, Australia, Poland, Bulgaria, Czechia, Netherlands
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia, Puerto Rico, United Kingdom
-
SanofiRecruitingMultiple SclerosisIsrael, United States, Canada, Puerto Rico, United Kingdom, Chile
-
Sanofi Pasteur, a Sanofi CompanyRecruitingHealthy Volunteers | Meningococcal InfectionUnited States, Puerto Rico
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Malignant Female Reproductive System Neoplasm | Recurrent Malignant Female Reproductive System NeoplasmUnited States
-
Oregon Health and Science UniversityUniversity of Missouri-Columbia; Vanderbilt University Medical CenterRecruitingHypertension | Multiple Chronic ConditionsUnited States
-
Eli Lilly and CompanyRecruitingObesity | Overweight and ObesityUnited States
-
BayerRecruitingUnresectable Hepatocellular CarcinomaGreece, Brazil, China, Colombia, Italy, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Thailand, United States, Argentina, France, Mexico, Turkey
-
Novo Nordisk A/SDuke Clinical Research InstituteNot yet recruitingCardiovascular Risk | Acute Myocardial Infarction (AMI)Canada, China, United States, Germany, Spain, Korea, Republic of, Netherlands, Australia, Italy, Denmark, India, United Kingdom, Argentina, Turkey, Mexico, Malaysia, Czechia, Poland, Brazil, France, Japan, Bulgaria, Greece, Israel